Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given a $60.00 price objective by investment analysts at Jefferies Group LLC in a research note issued on Wednesday. The firm currently has a “buy” rating on the stock. Jefferies Group LLC’s price objective would suggest a potential upside of 38.57% from the stock’s previous close. Jefferies Group also issued estimates for Acadia Healthcare’s Q4 2017 earnings at $0.68 EPS and FY2017 earnings at $2.45 EPS.

A number of other equities analysts also recently weighed in on the stock. Zacks Investment Research downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday. BidaskClub downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, August 18th. Deutsche Bank AG raised their target price on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Craig Hallum reaffirmed a “buy” rating and set a $65.00 target price (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Finally, UBS AG reaffirmed a “positive” rating and set a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $57.40.

Acadia Healthcare (NASDAQ ACHC) traded down 0.73% during trading on Wednesday, reaching $43.30. The company’s stock had a trading volume of 1,044,506 shares. Acadia Healthcare has a one year low of $32.54 and a one year high of $54.34. The firm has a market cap of $3.80 billion, a PE ratio of 475.82 and a beta of 1.07. The company has a 50-day moving average of $46.21 and a 200 day moving average of $46.34.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business had revenue of $715.90 million during the quarter, compared to the consensus estimate of $717.38 million. During the same quarter last year, the firm earned $0.73 earnings per share. The business’s revenue for the quarter was down 5.4% on a year-over-year basis. Analysts expect that Acadia Healthcare will post $2.45 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.americanbankingnews.com/2017/10/12/acadia-healthcare-company-inc-achc-pt-set-at-60-00-by-jefferies-group-llc.html.

In related news, Director William Grieco sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The shares were sold at an average price of $51.71, for a total transaction of $103,420.00. Following the completion of the sale, the director now owns 45,013 shares of the company’s stock, valued at $2,327,622.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Brent Turner sold 206,252 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the sale, the president now directly owns 81,106 shares of the company’s stock, valued at approximately $4,111,263.14. The disclosure for this sale can be found here. Insiders have sold 3,085,693 shares of company stock valued at $157,729,099 in the last three months. 11.10% of the stock is owned by insiders.

Hedge funds have recently modified their holdings of the stock. BNP Paribas Arbitrage SA boosted its holdings in Acadia Healthcare by 2,358.9% in the second quarter. BNP Paribas Arbitrage SA now owns 28,843 shares of the company’s stock worth $1,424,000 after purchasing an additional 27,670 shares during the last quarter. Oak Ridge Investments LLC boosted its holdings in Acadia Healthcare by 2.8% in the second quarter. Oak Ridge Investments LLC now owns 951,981 shares of the company’s stock worth $47,009,000 after purchasing an additional 26,043 shares during the last quarter. Mutual of America Capital Management LLC boosted its holdings in Acadia Healthcare by 47.8% in the second quarter. Mutual of America Capital Management LLC now owns 409,179 shares of the company’s stock worth $20,205,000 after purchasing an additional 132,356 shares during the last quarter. UBS Asset Management Americas Inc. boosted its holdings in Acadia Healthcare by 21.6% in the first quarter. UBS Asset Management Americas Inc. now owns 332,355 shares of the company’s stock worth $14,491,000 after purchasing an additional 59,001 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its holdings in Acadia Healthcare by 2.8% in the first quarter. Schwab Charles Investment Management Inc. now owns 290,396 shares of the company’s stock worth $12,662,000 after purchasing an additional 7,985 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.